70% of Major Pharmaceutical Companies and CROs Surveyed Have Adopted Digital Pathology

Proscia's new survey reveals that approximately 70% of life science organizations have invested in digital pathology to advance drug research and development. Over half of these organizations still use legacy software systems, primarily for basic image viewing, despite the growing adoption of artificial intelligence (AI) to accelerate the introduction of breakthrough therapeutics. The survey als..